Zhende Medical Hits Day High with Strong 3.37% Intraday Surge

Zhende Medical Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase of 3.37% on March 24, 2026. The stock reached an intraday high of CNY 92.00, reflecting its strong performance relative to the broader market. In comparison, the China Shanghai Composite index rose by 1.78% on the same day. Over the past month, Zhende Medical has shown a solid gain of 6.36%, while the Shanghai Composite has declined by 5.73%. The company's year-to-date performance stands at 30.5%, significantly outperforming the index, which has seen a decrease of 2.21%. Impressively, Zhende Medical's one-year performance has surged by 328.5%, far exceeding the Shanghai Composite's 15.17% growth. Despite these positive short-term trends, the company faces challenges with long-term growth metrics, including a decline in net sales and operating profit over the past five years. Nevertheless, the stock's current high dividend yield of 1.5% and a return on equity of 6.50% indicate a fair valuation in the market.